Brief: Lumos Pharma Reports Second Quarter 2021 Financial Results And Provides Clinical And Corporate Updates
05/08/2021 15:21
Aug 5 (Reuters) - Lumos Pharma Inc LUMO.O :
* LUMOS PHARMA REPORTS SECOND QUARTER 2021 FINANCIAL RESULTS
AND
PROVIDES CLINICAL AND CORPORATE UPDATES
* LUMOS PHARMA - CASH ON HAND AT Q2 END EXPECTED TO SUPPORT
OPERATIONS THROUGH PRIMARY OUTCOME DATA READOUT FROM
ORAGROWTH210 TRIAL IN H2 2023, ORAGROWTH212 TRIAL
* LUMOS PHARMA INC QTRLY NET LOSS PER SHARE OF COMMON STOCK
BASIC
AND DILUTED $1.04
Source text for Eikon: ID:nGNX2Txdh3
Further company coverage: LUMO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lumos Pharma
See all newsLumos Pharma Inc expected to post a loss of 76 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Apple, Hershey, Dow
U.S. STOCKS ON THE MOVE-Magnite, Nvidia, Tesla
Lumos Pharma climbs on $38 mln go-private deal
Brief: Lumos Pharma Enters Into Definitive Merger Agreement With Double Point Ventures To Go Private Via A Tender Offer Of $4.25 Cash Per Share Plus Contingent Value Rights (Cvr)